Sun Pharmaceutical Industries Ltd 2025 AR2
The report highlights Sun Pharma's financial and sustainability performance for the fiscal year 2024-25. The company achieved a 24.69% reduction in absolute Scope 1 and Scope 2 carbon emissions compared to its 2020 baseline, with renewable energy accounting for 49.77% of its energy mix. Additionally, Sun Pharma achieved its water conservation target ahead of schedule, recording a 31.70% reduction in water consumption. The company was also included in the S&P Global Sustainability Yearbook 2025, ranking in the top 5% of assessed pharmaceutical companies globally.
Company: Sun Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: AR2
Pages: 326
Back to company
Sun Pharmaceutical Industries Ltd
Annual Report
The report highlights Sun Pharma's financial and sustainability performance for the fiscal year 2024-25. The company achieved a 24.69% reduction in absolute Scope 1 and Scope 2 carbon emissions compared to its 2020 baseline, with renewable energy accounting for 49.77% of its energy mix. Additionally, Sun Pharma achieved its water conservation target ahead of schedule, recording a 31.70% reduction in water consumption. The company was also included in the S&P Global Sustainability Yearbook 2025, ranking in the top 5% of assessed pharmaceutical companies globally.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Published
May 22, 2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees